SUBSCRIBE
SUBSCRIBE

Synexa Life Sciences

Synexa Life Sciences is a biomarker and bioanalytical lab CRO, specialising in the development, validation and delivery of a wide range of complex and custom-designed assays.

With a team of over 200 staff across three global laboratory locations; Manchester, Turku (Finland) and Cape Town, we provide innovative solutions to support our customers to achieve their clinical milestones.

Our main areas of expertise include biomarker identification and development, large and small molecule clinical bioanalysis, (soluble) biomarker analysis (utilising MSD, LC-MS/MS, ELISA, RIA, fluorescence and luminescence-based technologies), cell biology (including flow cytometry, ELISpot and Fluorospot) and genomic services to support clinical trials and translational studies.

We pride ourselves on our deep scientific expertise and ability to tackle complex problems, translating them into robust and reliable assays to support clinical trial sample analysis.

NEWS
Business and financial crisis vector concept with businessman falling down the hole. Symbol of market crash, recession, risk, bankruptcy and loss. Eps10 illustration.
Company closure
iTeos To Close Down After TIGIT Fail
iTeos expects to absorb nearly $25 million in one-time costs for severance and termination payments. The biotech had 173 full-time employees at the end of 2024.
May 29, 2025
 · 
2 min read
 · 
Tristan Manalac
Tariffs
Novo Opposes Pharma Tariffs, Urges Crackdown on Illicit Chinese Semaglutide
In a letter to the Department of Commerce, Novo Nordisk argued that unsanctioned compounded semaglutide, mostly from China, constitutes a national security threat to the U.S.
May 29, 2025
 · 
2 min read
 · 
Tristan Manalac
Illustration showing a handshake, signaling cooperation, goodwill
Career Advice
Everyone Talks About Making a First Impression, But What About Your Last One?
Whether you’re moving on or being moved out, how you leave can shape your reputation more than how you led.
May 29, 2025
 · 
4 min read
 · 
Angela Justice
Pictured: Facade of Moderna's building in Massachusetts
Infectious disease
Moderna Loses $760M+ Government Bird Flu Contract as Vaccine Uncertainties Mount
The canceled contract comes as Moderna nears a critical FDA decision for its next-generation COVID-19 vaccine.
May 29, 2025
 · 
2 min read
 · 
Tristan Manalac
Illustration showing American flag with half-open door on the side
Job Trends
Sounding Off: Political Climate, Job Market Have Some Eyeing Biopharma Work Abroad
Nearly a third of employed and almost half of unemployed BioSpace survey respondents are seriously considering leaving the U.S. to find biotech and pharma jobs. Concerns about how the political climate is affecting biopharma are a key driver for many.
May 29, 2025
 · 
5 min read
 · 
Angela Gabriel
tax payment obligations, Tax officer's hand takes a piece of bread with a dollar logo
Drug pricing
Immuno-Oncology Stars Keytruda, Opdivo Likely To Come Into IRA Crosshairs
Leerink Partners previews the drugs likely to be subject to the Inflation Reduction Act’s next price negotiations as the program expands to Medicare Part B and smaller biotechs.
May 28, 2025
 · 
2 min read
 · 
Annalee Armstrong
shopping cart loaded with pills with dollar signs around it on a light blue background
Opinion
Drug Price Transparency in US Is Easier Said Than Done
A February executive order on pharmaceutical price transparency does nothing to change the incentives that keep costs opaque. But drug companies and other stakeholders would reap the benefits of such disclosures.
May 28, 2025
 · 
6 min read
 · 
Dennis Sponer
Loss of one drug name. Ban on a drug or its shortage. Exclusion from the list of free drugs available under the medical social program.
Rare diseases
InflaRx Axes Rare Skin Disease Study on Disappointing Late-Stage Data
InflaRx’s vilobelimab met the bar for futility in a Phase III trial for the rare skin disease pyoderma gangrenosum.
May 28, 2025
 · 
2 min read
 · 
Tristan Manalac
Medical syringe and bottle with liquid drug in continuous line art drawing style. Treatment, immunization and vaccination minimalist design. Vector illustration
Vaccines
RFK Jr. Removes CDC COVID Vaccine Recommendation for Healthy Children, Pregnant Women
In a video posted to social media on Tuesday, HHS Secretary Robert F. Kennedy, Jr. claimed that there is a lack of clinical data to support the repeat COVID-19 booster strategy in children.
May 28, 2025
 · 
3 min read
 · 
Tristan Manalac
Load More
Visit website
Email Us
IN THE PRESS
Press Releases
Waters Sets a New Benchmark for Robustness and Sensitivity for High-Throughput Labs with the Xevo TQ Absolute XR Mass Spectrometer
June 2, 2025
 · 
4 min read
BioMidwest
Inotiv, Inc. Announces New Site Openings and Expansions Supporting Additional Capacity and Service Offerings
December 8, 2022
 · 
4 min read
Business
Parexel Announces Strategic Collaboration with Synexa Life Sciences and Drawbridge Health for COVID-19 Clinical Serology Testing Solution
November 2, 2020
 · 
4 min read
JOBS